Dr. Reddy’s Laboratories Ltd (DRREDDY)

πŸ“Š End of Day Bhavcopy

Date: 2025-09-09

Price: 1294.40
% Change: 3.47% (Prev Close: 1251.00)

Volume: 16,43,726
% Change: 69.58% (Prev Volume: 9,69,297)

Delivery: 7,35,849
Delivery % : 44.77
% Change: 60.68% (Prev Delivery: 4,57,967)

Turnover: 21,067 Lacs
% Change: 72.64% (Prev Turnover: 12,202)

πŸ’Ή EOD Valuation

P/E Ratio: 19.01
P/B Ratio: 3.22
Market Cap: 108031 Rs. Cr.

Fundamental Data

Date: 05-09-2025

🏷️ Company Basics

Symbol: DRREDDY
Market Cap: 105166 Rs. Cr.
Face Value: 1.00 Rs.

52 Week High: 1405.90
52 Week Low: 1020.00

All-Time High: 1421.49 Rs.
All-Time Low: 60.50 Rs.

Stock Price Increase (% Return) %

% Return (1 mth |3 mth | 6 mth | 1 Yr | 3 Yrs | 5 Yrs):
3.90% | -4.44% | 11.38% | -7.02% | 14.41%

πŸ‘₯ Shareholding Pattern

Promoter Holding

Promoter Holding: 26.64%

Change (3Y | 1Y): -0.07% | 0.00%

Pledged %: 0.00%

FII Holding

FII Holding: 25.33%

Change (3Y | 1Y): -0.54% | -0.42%

DII Holding

DII Holding: 26.73%

Change (3Y | 1Y): 1.55% | 1.10%

Public Holding: 21.04%

🏦 Financial Strength

Debt to Equity: 0.14
Debt: 4676.60 Rs. Cr.

Book Value: 402.05 Rs.
Current Ratio: 1.66
Interest Coverage: 26.17
Free Cash Flow: 1327.40 Rs. Cr.

πŸ“ˆ Growth & Sales

Sales Growth: 15.79%

Sales Growth Qtr (YOY | QoQ):
11.38% | 0.51%

Sales Growth Yrs. (5 Yrs | 3 Yrs | 1 Yr):
13.26% | 14.86% | 15.79%

πŸ’° Profit & Earnings

Profit Growth %

Profit Growth: 2.08%

Profit Growth Qtr (YOY | QoQ):
1.85% | -11.14%

Profit Growth Yrs. (5 Yrs | 3 Yrs | 1 Yr):
22.28% | 38.02% | 2.08%

EPS Rs.

EPS (TTM): 68.08 Rs.

EPS Qtr (Last Year | Latest):
16.69 Rs. | 16.99 Rs.

EPS Annual (Last Annual | Annual March):
66.87 Rs. | 67.77 Rs.

EPS Growth Variation % (5 Yrs | 3 Yrs):
22.17% | 37.89%

Net Profit Rs. Cr.

Net Profit (TTM): 5742.70 Rs. Cr.

Net Profit (Annual - March): 5725.20 Rs. Cr.

Net Profit Qtr (Last Year Q | Previous Q | Latest Q):
1392.40| 1586.70 | 1409.90

EBITDA Rs. Cr.

EBITDA (Quarter): 2464.10 Rs. Cr.
EBITDA (Previous Yr Ql): 2323.00 Rs. Cr.

EBITDA (Annual - March): 9514.90 Rs. Cr.
EBITDA (Previous Annual): 8752.10 Rs. Cr.

EBITDA (5 Yrs | 3 Yrs) %:
24.71% | 31.23%

πŸ“Š Profitability Ratios

Operating Margin (OPM)

OPM (TTM): 25.42%

OPM Qtr (Previous | Current):
23.43% | 25.36%

OPM Annual (5 Yrs | Last Yr | March):
24.30% | 28.32% | 26.18%

Return on Equity %

ROE: 17.96%

ROE (5 Yrs | 3 Yrs | Last Yr):
17.46% | 20.10% | 21.39%

Return on Capital Employed %

ROCE: 22.69%

ROCE (5 Yrs | 3 Yrs | Last Yr):
21.11% | 25.32% | 26.53%

Return on Assets %

ROA (TTM): 12.95%

ROA (5 Yrs | 3 Yrs | Last Yr):
11.73% | 14.44% | 15.53%

PEG Ratio: 0.49
Dividend Yield: 0.63%

PE 3 Yrs: 19.63
PE 5 Yrs: 21.50

Dividend Yield: 0.63%

πŸ‘₯ Company

Dr. Reddy's Laboratories Ltd

DRREDDY

Promoter Holding: %